BrainsWay OCD is currently the only FDA approved platform TMS technology. It enables treatment of multiple indications, including MDD and OCD.
It’s the first non-invasive, novel FDA-cleared medical therapy for OCD in over a decade. BrainsWay’s H-coil technology enables targeting of multiple treatment areas.
Other current treatment methods are ineffective for a large segment of patients. Over 2 million adults are diagnosed with OCD every year. Approximately 50% of OCD patients are resistant to current firs-line treatment methods, including CBT and SSRI medication.
Many patients cannot tolerate medication side effects. Patients often discontinue SSRI’s due to debilitating side effects, such as; weight gain, sexual dysfunction, suicidal thoughts, nausea, insomnia, and anxiety. Common TMS side effects are a headache or mild discomfort at the application site. TMS is non-invasive, non-systemic, and has not been shown to cause any systemic side effects. Our TMS treatments are administered at our offices and do not require hospitalization or anesthesia.